We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01293123
Recruitment Status : Terminated (Did not meet enrollment goals)
First Posted : February 10, 2011
Last Update Posted : June 8, 2015
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Scott Letendre, University of California, San Diego

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2013
  Study Completion Date : December 2013